top of page
Screenshot 2024-12-12 at 2.23.53 PM.png
blue-macro-eye-close-260nw-1914725293_edited copy.jpg

REVOLUTIONARY
immune-profiling technology. 

TRANSFORMATIONAL SOLUTIONS THROUGH PRECISION IMMUNOTHERAPY

At Feromics, our diverse team of scientists, clinicians, and engineers reflects our commitment to transforming the future of immunotherapy and delivering groundbreaking therapies. Our solutions include novel drug candidates, proprietary cutting-edge single-cell technologies, and collaborative research initiatives that drive innovation and deliver real assets.

Solutions

DATA DRIVEN, ASSET FOCUSED.

IMMUNOTHERAPY

  • Uncover molecular pathways driving immune cell cytotoxicity and functionality to advance CAR-T and CAR-Treg therapies.

  • Applications:

       — Develop and optimize CAR-T constructs to enhance

           efficacy and persistence.

       — Develop and optimize CAR-Treg constructs for

           immune modulation to suppress overactive immune

          responses in autoimmune diseases.

PRECISION MEDICINE

  • Derisk preclinical and clinical development: optimize efficacy and patient outcomes through personalized immune profiling.

  • Donor selection: optimize allogeneic immunotherapies by selecting high efficacy donors.

  • Personalized immunotherapy: select an immunotherapy based on the patient’s immune profile.

R & D

REVOLUTIONARY

Revolutionary technology and workflow that accurately identify, isolate, and analyze unique immune cells that allow us to design novel immunotherapies and overcome the industry’s current limitations.

  • Oncology

  • Immunology

Platform

INNOVATIVE TECHNOLOGY & WORKFLOW

Bringing an engineering bottom-up approach to cell therapy, our Intelligent Design platform unlocks functional immunomics to help solve the biggest challenges in immunotherapy. Backed by our dedicated team of scientists, engineers, and clinicians, Feromics offers a robust, asset-focused drug discovery and development operation designed to accelerate innovation and deliver impactful results in immunotherapy and precision medicine.

Strategy

LEADING THE WAY IN PRECISION IMMUNOTHERAPY

Our strategic approach is designed to drive innovation and deliver transformative results in cancer and autoimmune disease treatments. Our commitment to precision, collaboration, and patient-centric care underpins every aspect of our strategy. 

Screenshot 2025-01-14 at 9.12.39 AM.png

PIPELINE

Feromics is actively applying its Intelligent Design platform toward the development of new therapies.

PROGRAM

PRE-CLINICAL

PHASE 1

PHASE 2

PHASE 3

Diffuse large B-cell lymphoma (DLBCL)

F01-50 ID-CAR-T

Undisclosed indication

F03-50 ID-CAR-T

bottom of page